User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Texture analysis on MR images helps predicting non-response to NAC in breast cancer.

  • Open access
  • PDF
  • 1.50 M
  1. Kaufmann Manfred, von Minckwitz Gunter, Smith Roy, Valero Vicente, Gianni Luca, Eiermann Wolfgang, Howell Anthony, Costa Serban Dan, Beuzeboc Philippe, Untch Michael, Blohmer Jens-Uwe, Sinn Hans-Peter, Sittek Rolf, Souchon Rainer, Tulusan Augustinos H., Volm Tanja, Senn Hans-Jörg, International Expert Panel on the Use of Primary (Preoperative) Systemic Treatment of Operable Breast Cancer: Review and Recommendations, 10.1200/jco.2003.01.136
  2. Heys Steven D., Hutcheon Andrew W., Sarkar Tarun K., Ogston Keith N., Miller Iain D., Payne Simon, Smith Ian, Walker Leslie G., Eremin Oleg, Neoadjuvant Docetaxel in Breast Cancer: 3-Year Survival Results from the Aberdeen Trial, 10.3816/cbc.2002.s.015
  3. van der Hage Jos A., van de Velde Cornelis J.H., Julien Jean-Pierre, Tubiana-Hulin Michelle, Vandervelden Cecile, Duchateau Luc, , Preoperative Chemotherapy in Primary Operable Breast Cancer: Results From the European Organization for Research and Treatment of Cancer Trial 10902, 10.1200/jco.2001.19.22.4224
  4. Mieog JS, van der Hage JA, van de Velde CJ. Preoperative chemotherapy for women with operable breast cancer. Cochrane Database Syst Rev. 2007;18:CD005002.
  5. Fisher B, Bryant J, Wolmark N, Mamounas E, Brown A, Fisher E R, Wickerham D L, Begovic M, DeCillis A, Robidoux A, Margolese R G, Cruz A B, Hoehn J L, Lees A W, Dimitrov N V, Bear H D, Effect of preoperative chemotherapy on the outcome of women with operable breast cancer., 10.1200/jco.1998.16.8.2672
  6. Barbi G.P., Marroni P., Bruzzi P., Nicolò G., Paganuzzi M., Ferrara G.B., Correlation between Steroid Hormone Receptors and Prognostic Factors in Human Breast Cancer, 10.1159/000226492
  7. von Minckwitz Gunter, , Sinn Hans-Peter, Raab Günter, Loibl Sibylle, Blohmer Jens-Uwe, Eidtmann Holger, Hilfrich Jörn, Merkle Elisabeth, Jackisch Christian, Costa Serban D, Caputo Angelika, Kaufmann Manfred, Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast, 10.1186/bcr1989
  8. Esserman Laura, Kaplan Elizabeth, Partridge Savanah, Tripathy Debasish, Rugo Hope, Park John, Hwang Shelley, Kuerer Henry, Sudilovsky Dan, Lu Ying, Hylton Nola, MRI Phenotype Is Associated With Response to Doxorubicin and Cyclophosphamide Neoadjuvant Chemotherapy in Stage III Breast Cancer, 10.1007/s10434-001-0549-8
  9. Nishimura Reiki, Osako Tomofumi, Okumura Yasuhiro, Hayashi Mitsuhiro, Arima Nobuyuki, Clinical significance of Ki-67 in neoadjuvant chemotherapy for primary breast cancer as a predictor for chemosensitivity and for prognosis, 10.1007/s12282-009-0161-5
  10. Fangberget A., Nilsen L. B., Hole K. H., Holmen M. M., Engebraaten O., Naume B., Smith H.-J., Olsen D. R., Seierstad T., Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging, 10.1007/s00330-010-2020-3
  11. Press Michael F., Sauter Guido, Buyse Marc, Bernstein Leslie, Guzman Roberta, Santiago Angela, Villalobos Ivonne E., Eiermann Wolfgang, Pienkowski Tadeusz, Martin Miguel, Robert Nicholas, Crown John, Bee Valerie, Taupin Henry, Flom Kerry J., Tabah-Fisch Isabelle, Pauletti Giovanni, Lindsay Mary-Ann, Riva Alessandro, Slamon Dennis J., Alteration of Topoisomerase II–Alpha Gene in Human Breast Cancer: Association With Responsiveness to Anthracycline-Based Chemotherapy, 10.1200/jco.2009.27.5644
  12. Chang Jenny C, Wooten Eric C, Tsimelzon Anna, Hilsenbeck Susan G, Gutierrez M Carolina, Elledge Richard, Mohsin Syed, Osborne C Kent, Chamness Gary C, Allred D Craig, O'Connell Peter, Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer, 10.1016/s0140-6736(03)14023-8
  13. von Minckwitz Gunter, Untch Michael, Blohmer Jens-Uwe, Costa Serban D., Eidtmann Holger, Fasching Peter A., Gerber Bernd, Eiermann Wolfgang, Hilfrich Jörn, Huober Jens, Jackisch Christian, Kaufmann Manfred, Konecny Gottfried E., Denkert Carsten, Nekljudova Valentina, Mehta Keyur, Loibl Sibylle, Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes, 10.1200/jco.2011.38.8595
  14. Woodhams Reiko, Matsunaga Keiji, Iwabuchi Keiichi, Kan Shinichi, Hata Hirofumi, Kuranami Masaru, Watanabe Masahiko, Hayakawa Kazushige, Diffusion-Weighted Imaging of Malignant Breast Tumors : The Usefulness of Apparent Diffusion Coefficient (ADC) Value and ADC Map for the Detection of Malignant Breast Tumors and Evaluation of Cancer Extension, 10.1097/01.rct.0000171913.74086.1b
  15. Woodhams Reiko, Kakita Satoko, Hata Hirofumi, Iwabuchi Keiichi, Kuranami Masaru, Gautam Shiva, Hatabu Hiroto, Kan Shinichi, Mountford Carolyn, Identification of Residual Breast Carcinoma Following Neoadjuvant Chemotherapy: Diffusion-weighted Imaging—Comparison with Contrast-enhanced MR Imaging and Pathologic Findings, 10.1148/radiol.2542090405
  16. Wu Lian-Ming, Hu Jia-Ni, Gu Hai-Yan, Hua Jia, Chen Jie, Xu Jian-Rong, Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in patients with breast cancer?, 10.1007/s10549-012-2033-5
  17. Tozaki Mitsuhiro, Sakamoto Masaaki, Oyama Yu, Maruyama Katsuya, Fukuma Eisuke, Predicting pathological response to neoadjuvant chemotherapy in breast cancer with quantitative1H MR spectroscopy using the external standard method, 10.1002/jmri.22118
  18. Murata, Pre-treatment with cyclophosphamide or OX40 (CD134) costimulation targeting regulatory T cell function enhances the anti-tumor immune effect of adoptively transferred CD8+ T cells from wild-type mice, 10.3892/mmr_00000146
  19. Ah-See M.-L. W., Makris A., Taylor N. J., Harrison M., Richman P. I., Burcombe R. J., Stirling J. J., d'Arcy J. A., Collins D. J., Pittam M. R., Ravichandran D., Padhani A. R., Early Changes in Functional Dynamic Magnetic Resonance Imaging Predict for Pathologic Response to Neoadjuvant Chemotherapy in Primary Breast Cancer, 10.1158/1078-0432.ccr-07-4310
  20. Martincich Laura, Montemurro Filippo, De Rosa Giovanni, Marra Vincenzo, Ponzone Riccardo, Cirillo Stefano, Gatti Marco, Biglia Nicoletta, Sarotto Ivana, Sismondi Piero, Regge Daniele, Aglietta Massimo, Monitoring Response to Primary Chemotherapy in Breast Cancer using Dynamic Contrast-enhanced Magnetic Resonance Imaging, 10.1023/b:brea.0000010700.11092.f4
  21. Li Sonia P., Makris Andreas, Beresford Mark J., Taylor N. Jane, Ah-See Mei-Lin W., Stirling J. James, d’Arcy James A., Collins David J., Kozarski Robert, Padhani Anwar R., Use of Dynamic Contrast-enhanced MR Imaging to Predict Survival in Patients with Primary Breast Cancer Undergoing Neoadjuvant Chemotherapy, 10.1148/radiol.11102493
  22. Loo Claudette E., Teertstra H. Jelle, Rodenhuis Sjoerd, van de Vijver Marc J., Hannemann Juliane, Muller Saar H., Peeters Marie-Jeanne Vrancken, Gilhuijs Kenneth G. A., Dynamic Contrast-Enhanced MRI for Prediction of Breast Cancer Response to Neoadjuvant Chemotherapy: Initial Results, 10.2214/ajr.07.3567
  23. de Bazelaire Cédric, Calmon Raphael, Thomassin Isabelle, Brunon Clément, Hamy Anne-Sophie, Fournier Laure, Balvay Daniel, Espié Marc, Siauve Nathalie, Clément Olivier, de Kerviler Eric, Cuénod Charles-André, Accuracy of perfusion MRI with high spatial but low temporal resolution to assess invasive breast cancer response to neoadjuvant chemotherapy: a retrospective study, 10.1186/1471-2407-11-361
  24. Uematsu Takayoshi, Kasami Masako, Yuen Sachiko, Neoadjuvant chemotherapy for breast cancer: correlation between the baseline MR imaging findings and responses to therapy, 10.1007/s00330-010-1813-8
  25. Pickles Martin D., Manton David J., Lowry Martin, Turnbull Lindsay W., Prognostic value of pre-treatment DCE-MRI parameters in predicting disease free and overall survival for breast cancer patients undergoing neoadjuvant chemotherapy, 10.1016/j.ejrad.2008.05.007
  26. Craciunescu Oana I., Blackwell Kimberly L., Jones Ellen L., Macfall James R., Yu Daohai, Vujaskovic Zeljko, Wong Terence Z., Liotcheva Vlayka, Rosen Eric L., Prosnitz Leonard R., Samulski Thaddeus V., Dewhirst Mark W., DCE-MRI parameters have potential to predict response of locally advanced breast cancer patients to neoadjuvant chemotherapy and hyperthermia: A pilot study, 10.1080/02656730903022700
  27. Bhooshan Neha, Giger Maryellen L., Jansen Sanaz A., Li Hui, Lan Li, Newstead Gillian M., Cancerous Breast Lesions on Dynamic Contrast-enhanced MR Images: Computerized Characterization for Image-based Prognostic Markers, 10.1148/radiol.09090838
  28. Holli Kirsi, Lääperi Anna-Leena, Harrison Lara, Luukkaala Tiina, Toivonen Terttu, Ryymin Pertti, Dastidar Prasun, Soimakallio Seppo, Eskola Hannu, Characterization of Breast Cancer Types by Texture Analysis of Magnetic Resonance Images, 10.1016/j.acra.2009.08.012
  29. Haralick Robert M., Shanmugam K., Dinstein Its'Hak, Textural Features for Image Classification, 10.1109/tsmc.1973.4309314
  30. Zhang Yunyan, Moore G. R. Wayne, Laule Cornelia, Bjarnason Thorarin A., Kozlowski Piotr, Traboulsee Anthony, Li David K. B., Pathological correlates of magnetic resonance imaging texture heterogeneity in multiple sclerosis : T2 MRI Texture, 10.1002/ana.23867
  31. Hajek M, Dezortova M, Materka A, Lerski R. Texture analysis for magnetic resonance imaging. Czech Republic: Med4 publishing; 2006. ISBN: 978-80-903660-0-8.
  32. Gibbs Peter, Turnbull Lindsay W., Textural analysis of contrast-enhanced MR images of the breast, 10.1002/mrm.10496
  33. Ahmed Arfan, Gibbs Peter, Pickles Martin, Turnbull Lindsay, Texture analysis in assessment and prediction of chemotherapy response in breast cancer : Texture Analysis in Breast Cancer MRI, 10.1002/jmri.23971
  34. Nie K, Chen J-H, Yu HJ, Chu Y, Mehta RS, Nalcioglu O, Su M-Y. Quantitative analysis of MRI tumor characteristics for neoadjuvant chemotherapy response prediction in breast cancer to the first-line doxorubicin-cyclophosphamide regimen and the AC followed by Taxane Regimen. In Proceedings of the 15th International Society for Magnetic Resonance in Medicine, abstract 558. Berlin: Publisher International Society for Magnetic Resonance in Medicine (ISMRM); 2007.
  35. Sahoo S, Lester SC. Pathology of breast carcinomas after neoadjuvant chemotherapy: an overview with recommendations on specimen processing and reporting. Arch Pathol Lab Med. 2009;133:633–42.
  36. Mudduwa L. Pathological parameters predicting HER-2/neu status of breast carcinoma. J Diagn Pathol. 2006;5:13–8.
  37. American College of Radiology. Breast imaging reporting and data system (BI-RADS). 4th ed. Reston: American College of Radiology; 2003.
  38. Liney Gary P., Gibbs Peter, Hayes Carmel, Leach Martin O., Turnbull Lindsay W., Dynamic contrast-enhanced MRI in the differentiation of breast tumors: User-defined versus semi-automated region-of-interest analysis, 10.1002/(sici)1522-2586(199912)10:6<945::aid-jmri6>3.0.co;2-i
  39. Likas Aristidis, Vlassis Nikos, J. Verbeek Jakob, The global k-means clustering algorithm, 10.1016/s0031-3203(02)00060-2
  40. Xiaoou Tang, Texture information in run-length matrices, 10.1109/83.725367
  41. Statistical Methods in Medical Research, ISBN:9780470773666, 10.1002/9780470773666
  42. DeLong Elizabeth R., DeLong David M., Clarke-Pearson Daniel L., Comparing the Areas under Two or More Correlated Receiver Operating Characteristic Curves: A Nonparametric Approach, 10.2307/2531595
  43. Pampel Fred, Logistic Regression, ISBN:9780761920106, 10.4135/9781412984805
  44. Baumann Knut, Cross-validation as the objective function for variable-selection techniques, 10.1016/s0165-9936(03)00607-1
  45. Rothman Kenneth J., No Adjustments Are Needed for Multiple Comparisons : , 10.1097/00001648-199001000-00010
  46. Place Andrew E, Jin Huh Sung, Polyak Kornelia, The microenvironment in breast cancer progression: biology and implications for treatment, 10.1186/bcr2912
  47. Kuhl Christiane, The Current Status of Breast MR Imaging Part I. Choice of Technique, Image Interpretation, Diagnostic Accuracy, and Transfer to Clinical Practice, 10.1148/radiol.2442051620
  48. Kershaw Lucy E., Cheng Hai-Ling Margaret, Temporal resolution and SNR requirements for accurate DCE-MRI data analysis using the AATH model, 10.1002/mrm.22573
  49. Yang Cheng, Karczmar Gregory S., Medved Milica, Oto Aytekin, Zamora Marta, Stadler Walter M., Reproducibility assessment of a multiple reference tissue method for quantitative dynamic contrast enhanced-MRI analysis, 10.1002/mrm.21912
  50. Li Xia, Welch E. Brian, Chakravarthy A. Bapsi, Xu Lei, Arlinghaus Lori R., Farley Jaime, Mayer Ingrid A., Kelley Mark C., Meszoely Ingrid M., Means-Powell Julie, Abramson Vandana G., Grau Ana M., Gore John C., Yankeelov Thomas E., Statistical comparison of dynamic contrast-enhanced MRI pharmacokinetic models in human breast cancer, 10.1002/mrm.23205
  51. Castellano G., Bonilha L., Li L.M., Cendes F., Texture analysis of medical images, 10.1016/j.crad.2004.07.008
  52. Ojala T., Pietikainen M., Maenpaa T., Multiresolution gray-scale and rotation invariant texture classification with local binary patterns, 10.1109/tpami.2002.1017623
  53. Kisku Dakshina Ranjan, Mehrotra Hunny, Gupta Phalguni, Sing Jamuna Kanta, SIFT-based ear recognition by fusion of detected keypoints from color similarity slice regions, 10.1109/actea.2009.5227958
  54. Depeursinge A, Foncubierta-Rodríguez A, Van De Ville D, Müller H. Multiscale lung texture signature learning using the Riesz transform. In: Proceedings of the 15th Medical Image Computing and Computer-Assisted Intervention (MICCAI), vol. 7512. Nice: Lecture Notes in Computer Science; 2012. p. 517–24.
  55. Loizou C P, Murray V, Pattichis M M, Seimenis I, Pantziaris M, Pattichis C S, Multiscale Amplitude-Modulation Frequency-Modulation (AM–FM) Texture Analysis of Multiple Sclerosis in Brain MRI Images, 10.1109/titb.2010.2091279
  56. Drabycz Sylvia, Mitchell J. Ross, Texture quantification of medical images using a novel complex space-frequency transform, 10.1007/s11548-008-0219-4
  57. Mallat S.G., A theory for multiresolution signal decomposition: the wavelet representation, 10.1109/34.192463
  58. Arlot Sylvain, Celisse Alain, A survey of cross-validation procedures for model selection, 10.1214/09-ss054
  59. Richard Raphael, Thomassin Isabelle, Chapellier Marion, Scemama Aurélie, de Cremoux Patricia, Varna Mariana, Giacchetti Sylvie, Espié Marc, de Kerviler Eric, de Bazelaire Cedric, Diffusion-weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer, 10.1007/s00330-013-2850-x
  60. Juntu J, Sijbers J, Van Dyck D. Classification of soft tissue tumors in MRI images using kernel PCA and regularized least square classifier. In: Proceedings of the 4th conference IASTED international conference. Innsbruck: Signal Processing, Pattern Recognition, and Applications; 2007. ISBN 978-0-88986-646-1.
  61. Cocquyt V.F., Blondeel P.N., Depypere H.T., Praet M.M., Schelfhout V.R., Silva O.E., Hurley J., Serreyn R.F., Daems K.K., Van Belle S.J.P., Different responses to preoperative chemotherapy for invasive lobular and invasive ductal breast carcinoma, 10.1053/ejso.2002.1404
  62. Tubiana-Hulin M., Stevens D., Lasry S., Guinebretière J. M., Bouita L., Cohen-Solal C., Cherel P., Rouëssé J., Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution, 10.1093/annonc/mdl114
Bibliographic reference Michoux, Nicolas ; Van den Broeck, Stéphane ; Lacoste, Laure ; Fellah, Latifa ; Galant, Christine ; et. al. Texture analysis on MR images helps predicting non-response to NAC in breast cancer.. In: BMC Cancer, Vol. 15, no. 1, p. 574 [1-13] (2015)
Permanent URL http://hdl.handle.net/2078.1/165085